Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-15-027798
Filing Date
2015-09-29
Accepted
2015-09-29 15:01:45
Documents
1
Period of Report
2015-09-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3772
  Complete submission text file 0001127602-15-027798.txt   5152
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 128 SPRING STREET, SUITE 520 LEXINGTON MA 02421
Business Address
Patel Sanj K (Reporting) CIK: 0001532218 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 151130614